Abstract
Since, the first report on cosmetic applications of non-ionic surfactant vesicles by L’Oreal, numerous papers have been published reporting success of niosomes in drug delivery. Niosomes are considered as one of the most successful drug carrier system applying nanotechnology to potentiate the therapeutic efficacy and reduce toxicities of conventional therapies. Niosomes are biodegradable, nontoxic and nonionic surfactants based vesicular drug carriers. The recent advancements in the pharmaceutical research are focused on the development of new delivery systems based on micro or nano-sized carriers to modulate the drug delivery, targeting as well as to improve the drug stability. Niosome are effective drug carrier with the ability of encapsulating both lipophilic and hydrophilic drugs. This laconic review exhaustively focuses on the potential of niosomal drug delivery with special emphasis on their role in drug targeting, advantages and disadvantages, formulation approaches and applications of niosomes in the disease therapy.
Keywords: Cholesterol, drug carrier systems, nanocarrier, niosomes, non-ionic surfactants, supercritical fluids.
Pharmaceutical Nanotechnology
Title:Frontier Lipid-Based Carrier Systems for Drug Targeting: A Laconic Review on Niosomes
Volume: 2 Issue: 3
Author(s): Rajendra Awasthi, Sumit Kumar and Giriraj T. Kulkarni
Affiliation:
Keywords: Cholesterol, drug carrier systems, nanocarrier, niosomes, non-ionic surfactants, supercritical fluids.
Abstract: Since, the first report on cosmetic applications of non-ionic surfactant vesicles by L’Oreal, numerous papers have been published reporting success of niosomes in drug delivery. Niosomes are considered as one of the most successful drug carrier system applying nanotechnology to potentiate the therapeutic efficacy and reduce toxicities of conventional therapies. Niosomes are biodegradable, nontoxic and nonionic surfactants based vesicular drug carriers. The recent advancements in the pharmaceutical research are focused on the development of new delivery systems based on micro or nano-sized carriers to modulate the drug delivery, targeting as well as to improve the drug stability. Niosome are effective drug carrier with the ability of encapsulating both lipophilic and hydrophilic drugs. This laconic review exhaustively focuses on the potential of niosomal drug delivery with special emphasis on their role in drug targeting, advantages and disadvantages, formulation approaches and applications of niosomes in the disease therapy.
Export Options
About this article
Cite this article as:
Awasthi Rajendra, Kumar Sumit and T. Kulkarni Giriraj, Frontier Lipid-Based Carrier Systems for Drug Targeting: A Laconic Review on Niosomes, Pharmaceutical Nanotechnology 2014; 2 (3) . https://dx.doi.org/10.2174/2211738503666150107234904
DOI https://dx.doi.org/10.2174/2211738503666150107234904 |
Print ISSN 2211-7385 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-7393 |
Call for Papers in Thematic Issues
Polymeric nanocarriers in drug delivery
Polymeric nanocarriers play a crucial role in drug delivery due to their versatility, and unique properties for targeting and modifying drug release. Their ability to enhance therapeutic outcomes, reduce side effects, and enable the delivery of drugs in a more targeted and controlled manner made them popular in the last ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Glycogen Synthase Kinase-3 (GSK3) in Psychiatric Diseases and Therapeutic Interventions
Current Drug Targets Cellular and Molecular Mechanisms of Tumor-Induced T-Cell Tolerance
Current Cancer Drug Targets Role of Mu and Delta Opioid Receptors in Alcohol Drinking Behaviour
Current Drug Abuse Reviews Inulin as a Delivery Vehicle for Targeting Colon-Specific Cancer
Current Drug Delivery Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts
Current Drug Safety Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR/ABL
Current Drug Targets Editorial: Pulmonary Involvement in Systemic Disorders
Current Drug Targets - Inflammation & Allergy Evaluation of the Risk/Benefit Ratio of Old and New Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Are the Antioxidant Properties of Carvedilol Important for the Protection of Cardiac Mitochondria?
Current Vascular Pharmacology Pharmacological Activation of p53 in Cancer Cells
Current Pharmaceutical Design Anti-cancer Scopes and Associated Mechanisms of Scutellaria Extract and Flavonoid Wogonin
Current Cancer Therapy Reviews Radiopharmaceuticals for Oncology Drug Development: A Pharmaceutical Industry Perspective
Current Pharmaceutical Design Chemotherapy and Delivery in the Treatment of Primary Brain Tumors
Current Clinical Pharmacology Chemomodulating Effects of Flavonoids in Human Leukemia Cells
Anti-Cancer Agents in Medicinal Chemistry Recent Patents Concerning Modulators of Protein Kinase C
Recent Patents on DNA & Gene Sequences Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia
Recent Patents on Anti-Cancer Drug Discovery Amino Acid Transporter-Targeted Radiotracers for Molecular Imaging in Oncology
Current Medicinal Chemistry The Role and Mechanism of Thiol-Dependent Antioxidant System in Bacterial Drug Susceptibility and Resistance
Current Medicinal Chemistry Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment
Current Neuropharmacology Defensin Participation in Innate and Adaptive Immunity
Current Pharmaceutical Design